Genedata’s Unparalleled Partner Symposium, 2026 Edition
March 12, 2026
The Genedata Partner Symposium 2026, our annual customer event, brought together scientific and technical professionals from across the biopharma industry for two days of focused, in‑depth exchange in Basel. Through plenary talks, breakout and poster sessions, and informal discussions, delegates shared real‑world experiences from their own R&D environments, highlighting what has worked, what has not, and where digital approaches are delivering biggest impact.
The discussions reflected a focus on building a robust data foundation, scaling automated workflows, and incorporating AI/ML into day‑to‑day scientific practice. Across domains spanning biotherapeutics discovery, CMC, and precision medicine, as well as complex technologies including mass spectrometry, chromatography, and NGS, participants explored both the opportunities and the challenges of making data more accessible, actionable, and impactful within their organizations.
Key Themes From the Discussions
Across sessions and informal exchanges, several common themes consistently surfaced.
A recurring focus was the importance of end-to-end workflow automation. Participants shared how standardized, scalable approaches to data management and processing are helping teams work more efficiently across sites and disciplines.
Another central theme was the role of a strong data foundation as a prerequisite for analytics and AI. Speakers and attendees emphasized the need for well-structured, high-quality data and integrated workflows to enable reliable, trustworthy insights.
Change management also featured prominently in the conversations. Discussions highlighted that successful digital transformation and AI adoption depend as much on people as on technology. Training, repeated enablement, visible successes and recognition, and broad engagement across teams were seen as essential.
Lab-in-the-loop also emerged as a prominent theme, showcasing the need for a much tighter integration of AI in automated workflows and scientific DMTA (design, make, test, analyze) cycles.
Speakers and attendees emphasized that while these approaches are designed to accelerate science, they still require scientific judgement. Maintaining human oversight, critical thinking, and contextual understanding was seen as essential to building trust and making defensible decisions.
The consensus was clear: AI can increase efficiency and accelerate innovation, but responsibility for interpretation and final decisions remains firmly with the scientist.
Recognizing Excellence in Data-Driven Biopharma R&D
Each year, the Genedata R&D Excellence Awards recognize outstanding contributions to digital biopharma R&D, spanning innovation, execution, enterprise-level transformation, and long-term leadership.
Innovation Award
The Genedata Innovation Award recognizes leaders who advance biopharma R&D through the application of digital technologies in pioneering and breakthrough ways. Wolfgang Reindl and Kelli Grand were honored for being the first to automate the analysis of SEC-MALS and ÄKTA data, from data acquisition to interpretation, establishing a scalable and consistent digital approach to complex analytical workflows that significantly expands what is possible to achieve in biopharma R&D.
Genedata Momentum Award
The Genedata Momentum Award honors individuals who drive sustained, measurable improvements in speed, efficiency, and time-to-insight through execution excellence. Sameh Eid was recognized for advancing automation across a complex scientific ecosystem by connecting Genedata solutions with internal systems, third-party tools, and CRO integrations, enabling scalable end-to-end workflows that support both current operations and future needs.
Genedata Transformation Award
The Genedata Transformation Award celebrates leaders who drive durable, enterprise-level change in R&D operating models. Tracie Fradet was honored for establishing, validating, and scaling NGS-based quality control operations at a global Center of Excellence at Astellas, transforming these workflows into GMP-validated, in-house assays and setting a new benchmark for quality control across cell, monoclonal antibody, and gene therapy programs.
Genedata Visionary Award
The Genedata Visionary Award recognizes lifelong leaders whose sustained influence has shaped digital biopharma R&D. Joel Bard was honored for his long-standing, cross-disciplinary leadership and pivotal role in establishing a scalable digital foundation across multiple therapeutic modalities, from antibody research and gene therapy initiatives to mRNA programs and ADC development.
Customer Perspectives From the Symposium
A defining aspect of the Genedata Partner Symposium is the opportunity for open exchange between peers across biopharma organizations and beyond. Throughout the event, attendees emphasized the value of hearing directly from other Genedata users and learning how teams across different organizations are approaching similar scientific and data challenges.
Many discussions centered on practical lessons learned, incremental improvements, or in some cases, more transformative leaps, as well as realistic approaches to introducing automation and AI into established R&D environments. Several attendees also noted that the symposium provides a rare space for candid, technically grounded conversations.
In‑Depth Exchange Beyond the Agenda
The symposium program included many opportunities for deep technical exchange. Beyond formal presentations, poster and demo sessions provided space for extensive discussions, with attendees engaging directly with speakers, peers, and Genedata experts.
This allowed participants to explore specific challenges in more detail, compare approaches, discuss trade-offs, and share experiences across therapeutic areas, technologies, and stages of R&D. For many participants, the informal conversations between sessions were even more valuable and inspiring than the talks themselves, reinforcing the collaborative nature of the event.
Many delegates left the symposium with fresh inspiration, new ideas about what to do better and what to do next, and a broader sense of what is possible beyond their previous expectations.
Learn more about the Genedata Partner Symposium
Discover more about the Genedata Partner Symposium and explore highlights and content from recent and past events.
Visit the Genedata Partner Symposium Webpage